Enlivex Ltd. Ordinary Shares (ENLV) is a publicly traded Healthcare sector company. As of July 7, 2026, ENLV trades at $0.49 with a market cap of $127.18M and a P/E ratio of 0.00. ENLV moved -5.16% today. Year to date, ENLV is -23.79%; over the trailing twelve months it is -56.60%. Its 52-week range spans $0.51 to $2.10. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces ENLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Enlivex Plans 1-for-15 Reverse Split, Issued Shares Cut to 16.83M: Enlivex will implement a 1-for-15 reverse stock split on July 9, reducing issued shares from 252.48 million to 16.83 million and authorized shares from 2.375 billion to 158.33 million. Par value will increase from NIS0.40 to NIS6.00 and warrants and options will adjust proportionately, with fractional shares rounded up.
| Metric | Value |
|---|---|
| Price | $0.49 |
| Market Cap | $127.18M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.10 |
| 52-Week Low | $0.51 |
| Volume | 691.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover ENLV: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.